Selective adrenergic uptake inhibitor - Neurocrine
Alternative Names: Selective norepinephrine reuptake inhibitor - Neurocrine; sNRI - Neurocrine BiosciencesLatest Information Update: 28 Feb 2008
At a glance
- Originator Neurocrine Biosciences
- Class
- Mechanism of Action Adrenergic uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neuropathic pain; Psychiatric disorders; Urinary incontinence
Most Recent Events
- 05 Feb 2008 Discontinued - Phase-I for Neuropathic pain in USA (unspecified route)
- 05 Feb 2008 Discontinued - Phase-I for Psychiatric disorders in USA (unspecified route)
- 05 Feb 2008 Discontinued for Urinary incontinence in USA (unspecified route)